International, Defence and Summits · 10 November 2026
NCB Annual Report 2025: Drone Drug Smuggling On India-Pakistan Border Up Over 10,000% In Five Years, Clandestine Labs Triple
Exam-focused facts from the 10 November 2026 current affairs briefing.
Key facts
- Drone-based drug smuggling cases along the India-Pakistan border rose from 3 in 2021 to 305 in 2025, an increase of about 10,067 per cent over five years.
- Punjab accounted for 298 of the 305 drone-related cases in 2025 and 461 kg of the total 468 kg of drugs seized through drone interceptions.
- Drugs seized through drone interceptions grew from 10 kg in 2021 to 468 kg in 2025, a 98 per cent rise over 2024; the Punjab haul included 449.751 kg of heroin and 9.018 kg of methamphetamine.
- Enforcement agencies dismantled 30 clandestine drug laboratories in 2025, up from 9 in 2021, 10 in 2022, 8 in 2023 and 9 in 2024, with 102 persons arrested in the laboratory-dismantling operations.
- Maharashtra, Rajasthan and Madhya Pradesh were identified as key centres of clandestine laboratory activity, and mephedrone was the most commonly manufactured drug in India's clandestine laboratories.
- Recoveries from multi-drug facilities dismantled in 2025 included 320.376 kg of mephedrone, 225.16 kg of ephedrine, 260.363 kg of pharmaceutical tablets containing psychotropic substances and 34,657 kg of other substances.
- Between 2021 and 2025 the NCB booked 110 darknet-related cases, while courier and postal channels saw 174 cases and 972 kg of drugs seized in 2025.
- The NCB report flags Myanmar in the Golden Triangle as a growing source of illicit opiates and synthetic drugs, with Manipur, Mizoram and Nagaland facing high exposure through Myanmar-linked trafficking networks.
- The report highlights the risk of diversion of precursor chemicals, particularly ephedrine and pseudoephedrine, into illicit manufacturing.